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Method
Measuring glycolytic flux in single yeast cells with
an orthogonal synthetic biosensor
Francisca Monteiro1,†,§, Georg Hubmann1,‡,§, Vakil Takhaveev1, Silke R Vedelaar1, Justin Norder1,
Johan Hekelaar1, Joana Saldida1, Athanasios Litsios1, Hein J Wijma2, Alexander Schmidt3 &
Matthias Heinemann1,*
Abstract
Metabolic heterogeneity between individual cells of a population
harbors significant challenges for fundamental and applied
research. Identifying metabolic heterogeneity and investigating its
emergence require tools to zoom into metabolism of individual
cells. While methods exist to measure metabolite levels in single
cells, we lack capability to measure metabolic flux, i.e., the ulti-
mate functional output of metabolic activity, on the single-cell
level. Here, combining promoter engineering, computational
protein design, biochemical methods, proteomics, and metabolo-
mics, we developed a biosensor to measure glycolytic flux in single
yeast cells. Therefore, drawing on the robust cell-intrinsic correla-
tion between glycolytic flux and levels of fructose-1,6-bispho-
sphate (FBP), we transplanted the B. subtilis FBP-binding
transcription factor CggR into yeast. With the developed biosensor,
we robustly identified cell subpopulations with different FBP levels
in mixed cultures, when subjected to flow cytometry and micro-
scopy. Employing microfluidics, we were also able to assess the
temporal FBP/glycolytic flux dynamics during the cell cycle. We
anticipate that our biosensor will become a valuable tool to iden-
tify and study metabolic heterogeneity in cell populations.
Keywords biosensor; fructose-1,6-bisphosphate; glycolytic flux; single cell; yeast
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Introduction
Increasing evidence suggests that individual cells in a population
can be metabolically very different (Nikolic et al, 2013; van Heerden
et al, 2014; Solopova et al, 2014; Kotte et al, 2015; Takhaveev &
Heinemann, 2018). Metabolic heterogeneity has been found, for
instance, not only in microbial cultures used for biotechnological
processes (Xiao et al, 2016), but also in cells of human tumors
(Strickaert et al, 2017). Because metabolic heterogeneity is
connected with productivity and yield losses in biotechnological
production processes (Xiao et al, 2016), and in cancer with limited
therapeutic successes (Robertson-Tessi et al, 2015), it is key to iden-
tify metabolic subpopulations and to understand their emergence.
Toward assessing metabolic heterogeneity, several novel experi-
mental tools have recently been developed to measure metabolite
levels in single cells (Qiu et al, 2019), e.g., by exploiting the autoflu-
orescence of specific metabolites (Papagiannakis et al, 2016),
Fo¨rster resonance energy transfer (FRET) (Hou et al, 2011), or
metabolite-binding transcription factors (Mahr & Frunzke, 2016).
For instance, transcription factor (TF)-based biosensors now exist to
detect amino acids (Mustafi et al, 2012), sugars (Raman et al,
2014), succinate and 1-butanol (Dietrich et al, 2013), triacetic acid
lactone (Tang et al, 2013), and malonyl CoA (Xu et al, 2014), partly
enabled by the transplantation of prokaryotic metabolite-responsive
TFs to eukaryotes (Ikushima et al, 2015; Li et al, 2015; Skjoedt et al,
2016; Wang et al, 2016; Ikushima & Boeke, 2017).
While measurements of metabolite levels in single cells are
already useful, knowledge of metabolic fluxes in individual cells
would often be more informative, as metabolic fluxes represent the
ultimate functional output of metabolism. Fluxes serve as predictor
of productivity in the development of cell factories (Nielsen, 2003)
or as indicator of disease (Zamboni et al, 2015). Here, particularly
knowing the flux through glycolysis would be valuable, as this flux
has been shown to correlate with highly productive phenotypes
(Gupta et al, 2017) and cancer (Pavlova & Thompson, 2016). While
nowadays metabolic fluxes can be resolved in ensembles of cells,
for instance, by means of 13C flux analysis (Antoniewicz, 2015),
inference of fluxes in individual cells, however, is not possible until
today (Takhaveev & Heinemann, 2018).
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One possible avenue toward measuring metabolic fluxes in indi-
vidual cells has recently emerged by the discovery of so-called flux-
signaling metabolites (Litsios et al, 2018), which are metabolites,
whose levels—by means of particular regulation mechanisms
(Kochanowski et al, 2013)—strictly correlate with the flux through
the respective metabolic pathway. Such flux signals are used by
cells to perform flux-dependent regulation (Kotte et al, 2010;
Huberts et al, 2012). Biosensors for such metabolites, such as
recently accomplished for E. coli (Lehning et al, 2017), would in
principle allow for measurement of metabolic fluxes in single cells,
in combination with microscopy or flow cytometry.
Here, drawing on the glycolytic flux-signaling metabolite fruc-
tose-1,6-bisphosphate (FBP) in yeast (Huberts et al, 2012; Hackett
et al, 2016; preprint: Kamrad et al, 2019) and using the B. subtilis
FBP-binding transcription factor CggR (Doan & Aymerich, 2003), we
developed a biosensor that allows for sensing FBP levels, and thus
glycolytic flux, in single yeast cells. To this end, we used computa-
tional protein design, biochemical, proteome, and metabolome anal-
yses (i) to develop a synthetic yeast promoter regulated by the
bacterial transcription factor CggR, (ii) to engineer the transcription
factor’s FBP-binding site toward increasing the sensor’s dynamic
range, and (iii) to establish growth-independent CggR expression
levels. We demonstrate the applicability of the biosensor for flow
cytometry and time-lapse fluorescence microscopy. We envision
that the biosensor will open new avenues for both fundamental and
applied metabolic research, not only for monitoring glycolytic flux
in living cells, but also for engineering regulatory circuits with
glycolytic flux as input variable.
Results
Design of biosensor concept
For our biosensor, we exploited the fact that the level of the glyco-
lytic intermediate fructose-1,6-biphosphate (FBP) in yeast strongly
correlates with the glycolytic flux (Christen & Sauer, 2011; Huberts
et al, 2012). Furthermore, we used the transcription factor CggR
from B. subtilis, to which FBP binds (Doan & Aymerich, 2003).
When bound to its target DNA, CggR forms a tetrameric assembly of
two dimers, through which transcription gets inhibited (Zorrilla
et al, 2007b). Upon binding of FBP to the CggR–DNA complex, the
dimer–dimer contacts of CggR are disrupted (Zorrilla et al, 2007a),
which decreases the overall CggR/operator complex stability, lead-
ing to increased CggR dissociation, and thus derepression of the
promoter (Chaix et al, 2010).
Here, we aimed to transplant the B. subtilis CggR to yeast and
have it exerting FBP-dependent and thus glycolytic flux-dependent
regulation of expression of a fluorescent protein. To this end, a
number of challenges had to be addressed. First, a synthetic
promoter had to be designed for the foreign transcription factor
CggR, involving the identification of ideal positioning and number
of operator sequences (Teo & Chang, 2014, 2015), and engineering
the nucleosome architecture to allow for maximal promoter activity
(Curran et al, 2014). Second, CggR had to be made responsive to
FBP in the correct dynamic range, requiring protein engineering
efforts (Raman et al, 2014; Rogers et al, 2015). Third, the CggR
expression levels needed to be such that together with the metabo-
lite-modulating effect on CggR, the TF can actually exert a regulating
effect on the promoter, for which we needed to identify proper CggR
expression levels (Fig 1).
In vivo test system for a substrate-independent and growth
rate-independent flux sensor
For later evaluation of the flux-reporting capacity of the developed
sensor, we first established an in vivo test system, through which
we could generate a range of glycolytic fluxes at steady-state
conditions. To this end, we employed a combination of growth
substrates and two different S. cerevisiae strains: the wild type
(WT) and a mutant strain (TM6), which only carries a single
chimeric hexose transporter and thereby only generates low
Figure 1. Illustration of the biosensor concept to measure glycolytic fluxes in single S. cerevisiae cells.
Expression of the bacterial transcriptional repressor CggR at constant levels, i.e., independent of growth rate and substrates. Binding of CggR as a dimer of dimers to the
operator (CggRO) of the synthetic cis-regulatory region, forming the CggR–DNA complex repressing transcription. At high glycolytic fluxes, fructose-1,6-bisphosphate (FBP)
levels are high and FBP binds to CggR disrupting the dimer–dimer contacts, which induces a conformational change in the repressor, such that transcription of the reporter
gene (YFP) can occur. The binding of FBP to CggR and consequent transcription is dependent on the FBP concentration, which correlates with glycolytic flux. The activity of the
glycolytic flux biosensor is measured by quantifying YFP expression. YFP expression levels are normalized through a second reporter, mCherry, under the control of TEF1
mutant 8 promoter (PTEFmut8), to control for global variation in protein expression activity.
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glucose uptake rates at high glucose levels (Elbing et al, 2004).
Metabolome and physiological analyses in combination with a
new method for intracellular flux determination (Niebel et al,
2019) showed that this combination of strains and conditions
allowed us to generate a broad range of glycolytic fluxes (Fig 2A).
Consistent with the earlier reported correlation between FBP levels
and glycolytic flux (Huberts et al, 2012), also here the FBP levels
had a strong linear correlation with the flux [r = 0.97, (0.95, 0.99)
95% confidence interval] (Fig 2A), but not with growth rate
(Fig 2B). This set of conditions and strains served as test system
for the to-be-developed glycolytic flux sensor.
Development of the synthetic CggR cis-regulatory element
First, we designed a synthetic CggR cis-regulatory element for yeast
(CggRO) based on the CYC1 promoter, which was previously
successfully re-designed (Curran et al, 2014). To accomplish repres-
sion of the promoter by CggR, we aimed to shield the TATA boxes
by the binding and tetramerization of the CggR dimers. The CYC1
core promoter has three TATA boxes at the positions 221, 169,
and 117, upstream of the open reading frame (Fig 3—upper part).
We flanked the two TATA boxes at positions 221 and 117 up-
and downstream with a CggR operator site. To conserve the geome-
try of the CYC1 core promoter as much as possible, we removed the
TATA box at position 169, because this TATA box was exactly
located where we integrated the CggR operator sites flanking the
other TATA boxes, and we did not want to make the sequence
longer. The 50UTR of the CYC1 promoter, which also included the
transcriptional start site, was kept. To allow for sole binding and
regulation through CggR, we removed the part further upstream of
the TATA box at the position 221 where, according to YEAS-
TRACT (Teixeira et al, 2014), the endogenous transcriptional bind-
ing sites of the CYC1 promoter are located.
A B
Figure 2. FBP concentration linearly correlates with glycolytic flux,
stronger than with growth rate.
A Glycolytic flux of wild type (WT) and TM6 strains strongly correlates with
fructose-1,6-bisphosphate (FBP) concentration. The glycolytic flux is
reported here as the flux between the metabolites fructose 6-phosphate
(F6P) and FBP. Glycolytic fluxes were obtained on the basis of physiological
and metabolome data, and via a novel method to estimate intracellular
fluxes (Niebel et al, 2019). While on high glucose, the WT strain
accomplishes a high glucose uptake rate (and thus glycolytic flux), the
mutant strain (TM6) only generates a low glucose uptake (and thus
glycolytic flux). On maltose, also the mutant strain achieves a high
glycolytic flux, since maltose is transported by a separate transporter
(Chang et al, 1989).
B FBP concentration as a function of cellular growth rate shows weaker
correlation.
Data information: For metabolite levels and growth rates, error bars
correspond to the standard deviation between three independent experiments,
for glycolytic fluxes to the mean and standard deviations of the sampled flux
solution space (cf. Materials and Methods). The carbon sources were used at a
final concentration of 10 g/l and are indicated: glucose (GLU); galactose (GAL);
maltose (MAL); and pyruvate (PYR). To assess the linear correlation between
the FBP concentration and the glycolytic flux (A) or growth rate (B) across the
studied conditions, we implemented Pearson’s correlation analysis assisted by
bootstrapping. Specifically, we used in total 53 FBP concentration
measurements corresponding to six different metabolic conditions
(combinations of strains and carbon sources), biological and technical
replicates. We paired each of these FBP measurements with the mean and
standard deviation of the model-derived glycolytic flux (A) or of the growth
rate (B) in the corresponding metabolic condition. We assumed the normal
distribution of the flux and growth rate with the given mean and standard
deviation in every condition, and implemented ordinary non-parametric
bootstrapping with 100,000 iterations by randomly sampling values with
replacement from the 53 FBP measurements and flux or growth rate
distributions to calculate the correlation statistics. In (A), Pearson’s coefficient
was found to be 0.97 with [0.95, 0.99] as the 95% confidence interval, and a P-
value smaller than 2.23e-308 (normal bootstrap). In (B), Pearson’s coefficient
was found to be 0.73 with [0.64, 0.80] as the 95% confidence interval, and P-
value equal to 2.28e-77 (normal bootstrap).
Figure 3. Design of the synthetic CggR cis-regulatory element.
The promoter design is based on the CYC1 core promoter. The relevant structural
elements of the CYC1 core promoter elements, which are required for
transcription, were conserved in the synthetic promoter design. These elements
comprised two TATA boxes at positions 221 and 117 (relative to the start of
the CYC1 ORF), and the 50UTR of the CYC1 core promoter (including
transcriptional start site, TSS). In the promoter design, three CggR operator sites
were inserted adjacent to the two TATA boxes. All functional elements were
conserved (blue colored region) during the optimization of the promoter
sequence. Nucleotide sequences between the functional elements (gray colored
region) were allowed to be optimized by the algorithm. Nucleotides that got
optimized are indicated with a black line. A total of 75 sequence versions were
generated, where each sequence differed in one mutation from the progenitor
sequence. The sequences were optimized for low nucleosome affinity. After
optimization, all sequences were checked for synthesis feasibility. The synthesis
of the sequences was feasible (green) until the 46th round. After this round, the
sequences (not feasible in red) reached a GC content insufficient for proper
synthesis. The promoter sequence, which was generated in round 38 (black),
showed the best compromise between minimal nucleosome affinity and the
possibility to synthesize the sequence.
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Using a computational method (Curran et al, 2014), we further
optimized this designed sequence of the CggR cis-regulatory element
to minimize nucleosome binding. Functional elements (e.g., the
CggR operator sites, the TATA boxes, and the 50UTR; cf.
Appendix Tables S1 and S2) were excluded from the sequence opti-
mization (Fig 3—lower part). A total of 75 computational optimiza-
tion rounds were applied. As the CggR cis-regulatory element
resembled a repetitive DNA sequence with a high AT content,
sequence variants were checked for DNA synthesis feasibility. The
cis-regulatory element of round 38 was the variant with the lowest
nucleosome affinity but with retained feasibility for DNA synthesis.
The synthesized synthetic promoter was integrated upstream of the
fluorescent reporter protein YFP (eCitrine) in a centromeric plasmid
ensuring a stable copy number.
Establishing a substrate-independent and growth
rate-independent CggR expression
Next, to drive expression of CggR, we needed a promoter that would
lead to condition-independent (i.e., constant) intracellular CggR
levels in order to ensure that the flux sensor only reports altered
FBP levels (i.e., glycolytic fluxes), and not altered CggR levels. To
this end, we tested the PCMV promoter, which is widely used as a
strong constitutive promoter in mammalian cells (Boshart et al,
1985), and two mutant variants of the endogenous TEF1 promoter,
i.e., mutant 2 (PTEFmut2) with low, and mutant 7 (PTEFmut7) with
medium-to-high expression strength (Nevoigt et al, 2006). Each
promoter and the CggR gene were cloned into the HO genomic locus
of both yeast strains.
To quantify the CggR protein levels, we performed proteome
analyses with the different strains, promoters, and growth condi-
tions. Overall, the three promoters yielded largely different CggR
abundances on glucose (Fig 4A). Across conditions and growth
rates, we found that the CggR levels when expressed from the PCMV
and PTEFmut2 promoters showed significant variations, while the
PTEFmut7 promoter generated more comparable CggR levels across
growth rates (Fig 4B), as established through the different carbon
sources and strains. Because of its more condition-independent
expression level, we selected the PTEFmut7 promoter to drive the
CggR expression.
Engineering the FBP affinity of CggR
Next, we needed to engineer the FBP binding to CggR, such that
it matches with the physiological range of FBP levels. FBP levels
in yeast range from 0.2 mM to around 8 mM (Fig 2A). As the wild--
type CggR has an affinity for FBP of around 1 mM (Bley Folly et al,
2018), we needed to generate a CggR mutant with a slightly lower
affinity for FBP, and with ideally a graded interaction between CggR
and FBP toward accomplishing a broad dynamic response range of
the sensor. Importantly, the engineered CggR would still need to
bind to the DNA, and furthermore, the protein should be stable to
not affect its cellular abundance.
To obtain such a CggR mutant, supported by computational
protein design methods, we identified mutations at the CggR–FBP-
binding site that could lead to the desired decrease in affinity.
Specifically, as in the CggR structure (3BXF) (Reza´cova´ et al,
2008) CggR binds to FBP through hydrogen bonds, and we
designed mutations to weaken or disrupt H-bonding interactions
(Table 1, Appendix Table S3), with the aim to decrease binding
affinity. The X-ray structure further showed that FBP binding
causes a conformational change in CggR (Reza´cova´ et al, 2008),
where a loop between residues G177 and Q185 moves away from
the FBP-binding site toward another subunit. On the basis of this,
we conjectured that mutations might not only influence FBP bind-
ing, but also alter the equilibrium between the normal and acti-
vated conformation, even in the absence of FBP. To predict the
effect of the mutations on this equilibrium, and on overall protein
stability, we used FoldX (Guerois et al, 2002), where we found
that a E269Q mutation could decrease overall stability while
R175K could permanently shift CggR to its activated conformation
(Table 1). Four mutations (i.e., T151S, T151V, T152S, and
R250A) were thus identified as promising candidates for decreas-
ing the FBP binding to CggR without otherwise negative effects
(Table 1).
We generated these CggR mutants with site-directed mutagene-
sis, expressed in E. coli, purified, and biochemically characterized
them. To this end, we used thermal shift assays to assess protein
stability and ligand binding. Most of the engineered CggR variants
maintained wild-type stability, with the exception of E269Q (consis-
tent with the above analysis) and T151V, which were less stable as
indicated by decreased melting temperatures (Fig 5A). While the
wild type had a KD of 1 mM FBP, the mutants T151S, E269Q, and
T152S showed a 1.1-, 1.5-, and 1.6-fold lower KD values, respec-
tively, while the KD values of the R250A and T151V mutants
increased 1.5- and 2.6-fold (Fig 5B).
A B
Figure 4. CggR intracellular levels and expression profile with different
promoters, strains, and conditions.
A CggR intracellular abundance in the wild-type (WT) strain on glucose
strongly varies with the promoter used. The CggR intracellular levels were
quantified by proteomics in steady-state cultures grown in minimal media
with glucose as carbon source at a final concentration of 10 g/l. Error bars
represent the standard deviation of at least three replicate experiments.
B The relative abundance of CggR (normalized to the abundance measured
on glucose and the same promoter) is almost constant with PTEFmut7 across
multiple growth rates in WT and TM6 cells, but not with PTEFmut2 and PCMV.
The CggR intracellular levels were quantified by proteomics in steady-state
cultures grown in minimal media with glucose, galactose, maltose, or
pyruvate as carbon sources at a final concentration of 10 g/l. WT data
include all three promoters, whereas TM6 only includes the PTEFmut2 and
PTEFmut7 data. Error bars represent the standard deviation of at least three
replicate experiments.
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To assess the DNA-binding capacity of the generated mutants,
we performed electro-mobility shift assays. We first measured the
percentage of CggR bound to DNA in the absence of FBP, reflecting
CggR’s binding affinity to DNA. Here, we found that the mutants
R175K and E269Q variants did not bind to the DNA anymore
(Fig 5C), and the mutant T151V only bound with lower affinity. The
other mutants had a comparable DNA binding as the wild-type
CggR. Next, using high (i.e., saturating) FBP levels (20 mM) to
maximally promote release of CggR from the DNA and comparing
the ratio between the percentage of the CggR bound to DNA,
obtained at 0 mM of FBP, divided by the bound fraction at 20 mM,
we found that only the R250A variant behaved similarly to the wild
type, with around 30% of the CggR remained bound to DNA at high
FBP levels (Appendix Fig S1). A comparison of the predicted mutant
features with the actually observed ones is shown in
Appendix Table S4.
Thus, as the R250A mutant fulfilled all desired criteria (Fig 5D),
i.e., it showed the desired decrease in FBP affinity, had a similar
stability and DNA-binding capability as the wild-type CggR, we
selected this mutant for the sensor. This mutant had the additional
advantage that it showed a flattened sigmoidal binding curve
(Fig 5A, R250A), which is ideal for a sensor that needs to respond
to a broad (cf. Fig 2A) FBP concentration range. The R250A muta-
tion eliminated the arginine side chain that made two H bonds with
the 6-phosphate group of FBP in the wild-type structure (Fig 5E)
and replaced it with a hydrophobic alanine side chain, which cannot
make H bonds.
Testing the glycolytic flux sensor
We implemented the flux-sensor elements in the wild type and
mutant (TM6) strains using either the wild-type CggR or the CggR
R250A mutant, genomically integrated into the HO locus under the
control of the TEF1 promoter mutant 7 (PTEFmut7). We added a
centromeric plasmid with the cis-regulatory CggR element (CggRO)
controlling YFP (eCitrine) expression. To normalize the YFP signals
for extrinsic cell-to-cell variation in the global state of the protein
expression machinery, we added the second fluorescent reporter
protein RFP (mCherry) to the plasmid, under the control of the
constitutive PTEFmut8 promoter (Nevoigt et al, 2006). Through
proteome analyses, we confirmed that CggR and mCherry expres-
sion levels correlate (Appendix Fig S2), validating the use of
mCherry to normalize YFP expression. To determine the sensor
output, i.e., the CggR activity, we quantified the YFP and mCherry
fluorescence levels by flow cytometry. We did not perform any spec-
tral compensation as spectral overlap is basically absent with the
applied fluorophores and filters (Appendix Fig S3). The ratio
between the YFP and mCherry fluorescence, each corrected for
autofluorescence determined by FACS, yielded the CggR repressor
activity.
First, we investigated which of the steps in the promotor engi-
neering were influencing the activity of the CggR cis-regulatory
element. To this end, we tested four promoter variants (Fig 6A,
Appendix Fig S4): (i) the wild-type CYC1 core promoter before the
introduction of the CggR cis-regulatory elements, (ii) the CYC1
promoter with the introduced CggRO elements, (iii) the CYC1
promotor with the introduced CggRO elements after the initializa-
tion of the optimization algorithm for the nucleosome positioning
(v1), and (iv) the CYC1 promotor with the introduced CggRO
elements, after optimization of the nucleosome affinity (v38), which
differs in 37 positions from (iii) (Appendix Fig S4). Here, we found
that the variants (i) to (iii) showed YFP fluorescence that is hardly
above the background fluorescence, while the promoter with the
optimized (i.e., lowest) nucleosome affinity showed much higher
expression levels (Fig 6B). The ratios between the YFP and mCherry
fluorescence for the different promoter variants underline the much
increased activity of the promoter with optimized nucleosome affin-
ity (Fig 6C). These results show that the sequence optimization was
indeed necessary.
Next, we used the engineered and nucleosome-optimized variant
of the promoter for both the wild type and mutant (TM6) strains
and grew these strains on the different carbon sources. Growth rate
analyses demonstrated that expression of the sensor constructs did
not alter growth (Appendix Fig S5) and titration effects can also be
Table 1. List of predicted mutations to alter CggR-FBP-binding affinity and stability.
Mutation
Expected effects on affinity for
FBP (and if relevant on
equilibrium and stability)a







T151S Negligible to mild affinity decrease 1.4 1.3 0.1
T151V Mild to strong affinity decrease 2.5 3.1 0.5
T152S Negligible to mild affinity decrease 7.3 4.6 2.7
R175K Negligible to strong affinity decrease
and possibly a shift of equilibrium to
the activated conformation
16.5c 0.7 17.2c
R250A Mild to strong affinity decrease 2.2 2.7 0.5
E269Q Mild to strong affinity decrease for
FBP in combination with overall
destabilization
16.4c 11.4c 5.0
aA detailed justification for the expected effects of the mutations on binding affinity is given in Appendix Table S4.
bA downshift in ΔΔGfold predicts stabilization of the protein, while a downshift in ΔΔΔGfold predicts that the FBP conformation becomes more favorable. ΔΔΔGfold
represents the difference between the ΔΔGfold values for the two conformations.
cValues are significantly higher than the standard deviation of FoldX predictions, which equals 3.4 kJ/mol (Guerois et al, 2002).
ª 2019 The Authors Molecular Systems Biology 15: e9071 | 2019 5 of 20




6 of 20 Molecular Systems Biology 15: e9071 | 2019 ª 2019 The Authors
Molecular Systems Biology Francisca Monteiro et al
excluded as CggR copy numbers are orders of magnitude lower than
the cellular FBP copy numbers. Here, consistent with our design
concept and the expected FBP-dependent derepression of the
synthetic promoter, we found a strong positive correlation between
the YFP/mCherry ratios and the intracellular FBP levels (Fig 6D)
and glycolytic flux (Fig 6E). This correlation was absent in control
strains lacking CggR (Fig 6D and E). Furthermore, consistent with
the growth rate-independent design of the sensor to respond solely
to FBP levels, we found no correlation between the sensor output
and the growth rate (Appendix Fig S6).
While the sensor with the wild-type CggR (i.e., not optimized
for FBP-binding affinity) displayed also a correlation with FBP
levels, the optimized version (in line with its lower FBP affinity)
displayed a dynamic response that better covered the physiologi-
cal concentration range of FBP (Fig 6D) and thus has a better
capability to distinguish different glycolytic flux values. When we
estimated the wild type and R250A CggR fraction bound to FBP,
we observed that the main differences occurred at intermediate
FBP levels (between 1.5 and 2.5 mM), in agreement with the fact
that the KD values of the two CggRs are around these FBP concen-
trations (Fig 6F).
Notably, the single point mutation in CggR (R250A) led to a dif-
ferent response curve (cf. Fig 6D), which is consistent with the fact
that the FBP affinity of CggR is in the range of the physiological FBP
concentrations, where small changes in the KD value lead to signifi-
cant changes in the response. Further, as the point mutation solely
altered the affinity to FBP (Fig 5B), but not its DNA affinity (Fig 5C),
stability (Fig 5D) nor its cellular abundance (Appendix Fig S7), this
demonstrates that the sensor’s output exclusively depends on the
changing FBP levels. Thus, these data demonstrate that we have
generated a sensor for FBP and, as FBP levels correlate with glyco-
lytic flux (Fig 2A), a sensor that robustly and specifically reports
glycolytic flux. While the wild type and the mutant (TM6) strains
used here have very different glycolytic flux levels during growth on
glucose (Fig 2A), notably, our sensor unmasks this difference even
though the environment was identical.
Altogether, this demonstrates that the recorded fluorescence ratio
specifically responds to FBP levels. Because of its correlation with
glycolytic flux (Huberts et al, 2012), this means that we have gener-
ated a sensor that reports glycolytic flux. In cases where the glyco-
lytic fluxes are expected to change over a broad range, the use of
the mutant CggR is most advisable, but in cases where high resolu-
tion is needed at low glycolytic fluxes, the use of the wild-type CggR
might be preferred.
Application of the sensor
Toward testing and applying the sensor, we first asked whether we
could detect subpopulations with different glycolytic fluxes with
flow cytometry. To this end, we mixed wild type and TM6 cells
grown on glucose at different proportions. By plotting the single-cell
signals from the YFP against the mCherry channel, we could clearly
identify two clouds corresponding to the two strains (Fig 7A). Histo-
grams over the single-cell YFP/mCherry ratios showed that with the
glycolytic flux difference as present between the wild type and the
TM6 cells on glucose, subpopulations with a minimal fraction of
about 5% can be discovered with flow cytometry (Fig 7B).
Next, we aimed to test the engineered flux sensor with regard to
its capability to detect single-cell differences in glycolytic flux when
using microscopy, offering the possibility to co-assess other parame-
ters, such as growth and cell division. First, we confirmed that also
with the microscopic setup the output of the flux sensor still
displays a linear correlation with glycolytic flux across conditions
and strains (Fig 7C, Appendix Fig S8A). Next, we used microfluidics
and time-lapse microscopy to cultivate the TM6 strain on glucose,
where we recently showed that dividing cells with high flux co-exist
with a small isogenic fraction of non-dividing cells with low glyco-
lytic flux levels (Litsios et al, 2019). Here, using the sensor, we
found that non-dividing cells had indeed significantly lower YFP/
mCherry ratios, even visibly by eye, compared with their co-existing
dividing counterparts (Fig 7D and E, Appendix Fig S8B), in line with
their lower glycolytic flux. These results demonstrate that our flux
sensor can be also used with microscopy, and is thus suitable for
discrimination of individual cells with regard to their glycolytic flux
levels, even within clonal cell populations.
To investigate whether the engineered biosensor can also be
applied to study metabolic dynamics in single cells, we employed it
to assess the FBP concentration, and thus the glycolytic flux, during
the cell cycle. We cultivated TM6 cells with the sensor on high
glucose in the microfluidic device, continuously measured with
microscopy YFP and mCherry signals as well as cell volume, and
identified budding and cytokinesis to demark cell cycles and their
phases. Toward obtaining a biosensor readout suitable for reporting
momentary FBP levels during the cell cycle, we abandoned the ratio
of the YFP and mCherry signals since these signals result from the
fluorescent-protein expression over a long period of time. Instead,
we determined the momentary YFP and mCherry production
rates, and used their uncoupling as a proxy for momentary FBP
concentration.
◀ Figure 5. Biochemical characterization of CggR and respective mutants.A Thermal shift assays were used to determine the melting curves of wild-type CggR and mutants. Error bars correspond to the standard deviation of at least five
replicates.
B CggR-FBP affinity constants (KD’s) of the wild type and mutant variants, determined by fitting a simple cooperative binding model to the melting curves data. Error
bars indicate the 95% confidence intervals.
C Quantification of CggR binding to DNA. The CggR bound to DNA fraction was calculated by dividing the intensity of the protein–DNA complex band by the total DNA.
The background-subtracted total intensities of the CggR–DNA complex and the free-DNA bands were assessed with ImageJ. Error bars correspond to the standard
deviation of three replicate experiments for the mutants and six for the wild type.
D Summary of the biochemical characterization of the wild type and mutant CggR variants. KD ratio change indicates the ratio between the KD of the CggR mutant
variant and one of the wild type. A plus sign indicates desired characteristics achieved in the mutants; a minus sign indicates undesired effects of the mutations. The
mutant highlighted with gray background is the one we selected for further analyses, as this mutant had the desired characteristics with regards to all three criteria.
E Ray-traced picture of the wild-type CggR and R250A mutant structure. Carbon atoms of the FBP ligand are in turquoise while the part of the side chain that is
eliminated by the R250A mutation is in green. Hydrogen bonds are indicated with dashed lines.
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Figure 6. The engineered flux-sensor reports glycolytic flux with a high dynamic flux range.
A Overview about the different design steps in our promotor engineering strategy (cf. also Appendix Fig S4).
B The four reporter plasmids were transferred to the wild-type strain containing the CggR (R250A) under the control of the PTEFmut7. The strength of the four
promoters was assessed by quantifying YFP (FL1) and mCherry (FL3) fluorescence in exponentially growing wild-type cells in minimal medium with 10 g/l glucose.
The FL1 and FL3 fluorescence shown is the non-background-corrected median of 100,000 cell events. The non-FL control is the signal from a wild-type strain
grown under the same conditions. Error bars represent the standard deviation of three independent experiments.
C The background fluorescence, assessed by the wild-type harboring the YCplac33 plasmid, was subtracted from FL1 and FL3. The final reporter activity is the ratio of
the background-corrected YFP and mCherry values. Error bars represent the standard deviation of three independently determined ratios from three replicate
experiments.
D, E Reporter activity of the sensor across (D) multiple FBP levels and (E) glycolytic fluxes. The glycolytic flux is reported as the flux between the metabolites fructose
6-phosphate (F6P) and fructose-1,6-bisphosphate (FBP). Glycolytic fluxes were here estimated on the basis of physiological and metabolome data and a novel
method to estimate intracellular fluxes (Niebel et al, 2019). Reporter activity is given by the YFP/mCherry ratio, calculated through the quantification of YFP and
mCherry fluorescence along culture time using flow cytometry. Both YFP and mCherry fluorescence levels were first corrected for background using the same
strains harboring the YCplac33 plasmid (Appendix Table S8). The control is the wild type and TM6 strains expressing only the reporter plasmid without CggR. Error
bars represent the standard deviation of at least three replicate experiments.
F Fraction of CggR bound to FBP across FBP concentrations. The red arrows indicate the shift in the percentage of CggR bound to FBP achieved in the R250A variant.
The percentage of CggR molecules bound to FBP was calculated after normalizing the Tm values for unbound/bound state using the Tm at 0 mM FBP as unbound
and at 36 mM (corresponding to maximum FBP concentration used) as total bound states. The curve fitting of the normalized values of CggR fraction bound to
FBP was performed using a one-site specific binding model in GraphPad. The solid line corresponds to the wild-type CggR and the dashed line to the R250A
variant. Vertical lines delimit the physiological FBP range.
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Here, we found that in cells expressing the biosensor (i.e., CggR
and the reporter plasmid) the YFP and mCherry production rates are
uncoupled during the cell cycle, with YFP being produced faster rela-
tive to mCherry around cytokinesis and in G1, but markedly slower in
the middle of S-G2-mitosis (Fig 7F, Appendix Fig S10A). In the strain
without CggR (unregulated control), we observed no uncoupling
between the YFP and mCherry production rates (Fig 7G, Appendix Fig
S10B). Since YFP expression is controlled by FBP in the biosensor, this
result showed that the FBP concentration, and thus glycolytic flux,
change during the cell cycle, peaking around cytokinesis and in the G1
phase, inline with recent work (Litsios et al, 2019). This experiment
demonstrates that the biosensor is also applicable to assess the
dynamic behavior of metabolism in single cells.
Discussion
Here, exploiting the flux-signaling metabolite fructose-1,6-bispho-
sphate and the bacterial transcription factor CggR, we developed a





Figure 7. The glycolytic flux sensor can measure glycolytic flux in individual cells.
A Subpopulations of WT and TM6 cells, grown separately and mixed in different fractions as indicated in percentages, can easily be distinguished by flow cytometry,
FL1 YFP channel, FL3 mCherry channel.
B Histogram of single-cell ratios of FL1/FL3 fluorescence intensities of mixed WT and TM6 populations analyzed by flow cytometry. Here, a subpopulation of
minimally 5% can be distinguished.
C Tukey boxplots showing the YFP/mCherry ratio of individual cells measured by microscopy as a function of glycolytic flux. At least 35 cells were analyzed in each
condition. The glycolytic flux is here reported as the flux between the metabolites fructose 6-phosphate (F6P) and FBP. Glycolytic fluxes were estimated on the
basis of physiological and metabolome data and a novel method to estimate intracellular fluxes (Niebel et al, 2019). The boxplot horizontal line indicates the
median and the box extends from the 25th to 75th percentiles. Plotted points are outliers that are higher or lower than the upper and lower whiskers, respectively.
D YFP/mCherry ratio measured by microscopy in co-existing dividing (high flux) versus non-dividing (low flux) isogenic TM6 cells on 10 g/l glucose. Each data point
corresponds to data from a single cell.
E Brightfield (BF), YFP, and mCherry microscopy images for a co-existing dividing (high flux) and a non-dividing (low flux) TM6 cell expressing the flux sensor in
10 g/l glucose minimal medium.
F, G The production rates of YFP and mCherry are uncoupled during the cell cycle in the biosensor-expressing strain (F), which reflects the cell-cycle dynamics of
intracellular FBP concentration and glycolytic flux. In a control strain, lacking CggR, the production rates of YFP and mCherry are coupled (G). The uncoupling was
calculated for individual cell-cycle trajectories as the difference between the YFP and mCherry production rates normalized to have the same scale (see more
details in Materials and methods; Appendix Fig S10). Each curve represents the mean across the indicated number of cell cycles in a replicate experiment. The
corresponding shaded areas denote the 95% confidence intervals of the means (bootstrapping with 5,000 iterations). We smoothed the single-cell-cycle trajectories
of YFP and mCherry signals as well as cell volume via the Gaussian process regression, and used these trajectories to derive the YFP and mCherry production rates,
accounting for fluorescent-protein maturation in a first-order kinetics model. To align the cell-cycle trajectories and to calculate the phase, we used the array of
three cell-cycle events E {cytokinesis (cyt), budding, next cyt} as reference points. Specifically, we computed the average cell-cycle-relative timing for each of these





, where N is the number of cell cycles in the replicate of interest, and tecc is the time in minutes when
the event e happens in the cell cycle cc. The orange vertical lines denote ubudding for both replicates. In the aligned cell cycles, we converted the time in minutes t to
the phase ucc in the following way: ucc ¼ uE½iþ1  uE½i
  ttE½icc
tE½iþ1cc tE½icc
þ uE½i for t 2 tE½icc , tE½iþ1cc
h i
if E[i] = cyt or t 2 tE½icc , tE½iþ1cc
 
if E[i] 6¼ cyt, where i is the index
number of an event in the array E. The cell cycles used for the analysis had the duration in the interval between 150 and 300 min, with the mean duration
presented in parentheses for each replicate experiment. The cells belonged to the TM6 strain and were cultivated on 20 g/l glucose in the microfluidic device.
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yeast cells, at least under glycolytic conditions. These engineering
efforts, for which we used computational protein design, biochemi-
cal, proteome, and metabolome analyses, entailed (i) development
of a synthetic yeast promoter regulated by the bacterial transcrip-
tional factor CggR, (ii) engineering of the transcription factors’ FBP-
binding site toward increasing the sensor’s dynamic range, and (iii)
establishment of growth-independent CggR expression levels.
Through single-cell flow cytometry and time-lapse fluorescence
microscopy experiments, we demonstrated the applicability of the
sensor to reveal differences in glycolytic flux between single cells.
Biosensor development based on transcription factors has
recently seen rapid development (Rogers et al, 2016; Lehning et al,
2017; Liu et al, 2017; Carpenter et al, 2018). Yet, three aspects of
our work are worth to be highlighted: As no endogenous FBP-
binding transcription factor is known in yeast, we had to transfer
the B. subtilis transcription factor CggR into yeast. However, unlike
previous studies, which transplanted bacterial transcription factors
into eukaryotes (Teo & Chang, 2015; Wang et al, 2016; Rantasalo
et al, 2018), to ensure full orthogonality of the introduced sensing
system to the host, we avoided the use of yeast-endogenous
elements, such as DNA-binding domains or chimeric fusions of TF
with transcriptional activation domains, and the use of a nuclear
localization sequences. Instead, in our design, we build the
promoter from scratch and exploited the natural mode of action of
the TF also in the new host. Specifically, we used the ability of CggR
to dimerize to allow for an effective repression mechanism also in
yeast. Furthermore, and also in contrast to previous promoter engi-
neering approaches, which often employed FACS-based screening
approaches with large promoter libraries (Skjoedt et al, 2016), our
approach was not a screening but a rational design approach. Our
successful de novo engineering of a cis-regulatory element demon-
strates that rational promoter development is possible when taking
crucial factors into account, such as positioning and number of cis-
regulatory elements, the transcription factor’s mode of action, and
the genomic context, i.e., nucleosome affinity.
A second important aspect in our biosensor development was
that we made sure that the output of the sensor is not influenced by
growth-dependent changes in the transcription factor’s expression
level, as its concentration also determines the synthesis rate of the
gene product, and thus the output signal. In previous work,
this point has mostly been ignored and TFs were typically “constitu-
tively” expressed, although unregulated expression does not neces-
sarily lead to constant expression level across different growth rates
(Klumpp et al, 2009). Constant and condition-independent levels of
the transcription factor are particularly important in light of a glyco-
lytic flux sensor, which likely will be applied across growth condi-
tions. To accomplish growth rate-independent expression levels,
using quantitative proteomics, we found that the PTEFmut7 promoter
leads to more or less condition-independent levels of CggR, while
two other tested constitutive promoters, i.e., PCMV and PTEFmut2,
showed strong growth-dependent expression levels. We hope that
future development work toward transcription-dependent biosen-
sors will also consider the expression level of the TF as an important
element in the development of the sensor.
Another important aspect in our biosensor development was the
optimization of the biosensor’s dynamic range with regard to
the sensed FBP levels and thus glycolytic fluxes. Here, we lowered
the CggR–FBP-binding affinity to better cover the range of the
intracellular FBP levels. Optimizing TF-effector sensitivity is not
trivial, because transcription factors contain both an effector-
binding domain and a DNA-binding domain, which should not be
altered when engineering the former. Here, we applied a semi-
rational design approach, supported by computationally guided
protein design, to select mutants with lower FBP–CggR-binding
activity and unaltered CggR–DNA-binding capacity. Demonstrating
the challenge, only one mutation (R250A), out of a pool of 11
mutants, showed all desired features. Relevant for future engineer-
ing, only the mutations where the H-bond forming side chains were
eliminated (R250A and T151V) resulted in the desired affinity loss.
Furthermore, computational modeling with FoldX on the basis of
available X-ray structures of both the normal and the activated
conformation of the CggR effector-binding domain allowed to
predict the instability or DNA-loss binding of some variants, indicat-
ing that computational stability predictions can successfully elimi-
nate at least some dysfunctional mutants.
To construct the biosensor for glycolytic flux in yeast, we
exploited the function of fructose-1,6-bisphosphate as a flux-
signaling metabolite (Huberts et al, 2012) and we took advantage of
the fact that FBP modulates the conformation of the B. subtilis tran-
scription factor CggR (Doan & Aymerich, 2003). Can a similar
approach be pursued to develop flux sensors also for other meta-
bolic pathways? This seems possible: On the basis of metabolite
dynamics assessed across various nutrient conditions and known
metabolite–protein and metabolite–RNA interactions, we recently
compiled a list of several other candidates of flux-signaling metabo-
lites (Litsios et al, 2018), which includes citrate, alpha-ketogluta-
rate, phosphoenolpyruvate, pyruvate, and succinate. Exploiting
respective metabolite-binding transcription factors and engineering
biosensors for these metabolites should yield flux sensors also for
other pathways. For instance, for citrate, whose concentration corre-
lates with the cellular nitrogen flux (Fendt et al, 2013), the tran-
scriptional activator CitI from lactic acid bacteria (Martin et al,
2005) would be an excellent starting point. Thus, as flux-signaling
metabolites also exist for other metabolic pathways (Litsios et al,
2018), and transcription factors exist for many of these metabolites
(Reznik et al, 2017), it should be possible to develop flux biosensors
also for other metabolic pathways.
We envision that our glycolytic flux biosensor, applicable in single
living yeast cells, will find applications in fundamental research with
Saccharomyces cerevisiae, i.e., to address the daunting emergence of
metabolic heterogeneity as occurring during replicative aging (Leupold
et al, 2019) or cellular growth (van Heerden et al, 2014; Kiviet et al,
2014; Thomas et al, 2018) or to investigate metabolic dynamics during
the cell cycle (Papagiannakis et al, 2016; Litsios et al, 2019). Further-
more, we expect that the biosensor will also have value for applied
research. Metabolic heterogeneity is a significant problem in industrial
fermentations, especially those with cell recycling as applied in beer
brewing and bioethanol production (Stewart et al, 2013; Aranda et al,
2019; Wang et al, 2019), where physiological and genetic changes can
cause losses in fermentation performance (Powell et al, 2003). In such
large-scale yeast applications, our glycolytic flux sensor will provide a
tool to study how and why metabolic subpopulations with high or low
glycolytic flux phenotypes emerge. Beyond, we expect that the biosen-
sor will find its application also as a screening tool in metabolic engi-
neering efforts, for instance to screen for highly productive
phenotypes, rather than just for selecting on growth.
10 of 20 Molecular Systems Biology 15: e9071 | 2019 ª 2019 The Authors
Molecular Systems Biology Francisca Monteiro et al
Materials and Methods
Reagents and Tools table
Reagent/Resource Reference or source Identifier or catalog number
Experimental models
Saccharomyces cerevisiae wild-type (WT) ura− (Elbing et al, 2004) N/A
Saccharomyces cerevisiae TM6 (Elbing et al, 2004) N/A
Recombinant DNA




p416-loxP-KmR-TEFmut2-yECitrine (Nevoigt et al, 2006) N/A
p416-loxP-KmR-TEFmut7-yECitrine (Nevoigt et al, 2006) N/A
p416-loxP-KmR-TEFmut6-yECitrine (Nevoigt et al, 2006) N/A
p416-loxP-KmR-TEFmut8-yECitrine (Nevoigt et al, 2006) N/A
pHO_pCMV_CggR_ble This study N/A
pHO_pTEFmut2_CggR_ble This study N/A
pHO_pTEFmut7_CggR_ble This study Addgene 124584
pHO_pTEFmut2_CggR_R250A_ble This study N/A
pHO_pTEFmut7_CggR_R250A_ble This study Addgene 124585
pBS35 Yeast Resource Center pBS35
pWHE601 Beatrix Suess Lab N/A
pYCplac33 ATCC 87586
pTEF6-7 This study Addgene 124583
pCggRO reporter This study Addgene 124582
Additional plasmid information This study Appendix Table S5
Oligonucleotides and other sequence-based reagents
PCR primers This study Appendix Tables S6, S7 and S9
Chemicals, enzymes, and other reagents
Phusion® High-Fidelity DNA Polymerase New England Biolabs M0530
Antarctic phosphatase New England Biolabs M0289
T4 DNA ligase New England Biolabs M0202
Trypsin spectrometry grade Promega V5280
DpnI New England Biolabs R0176
SYPRO® Orange Protein Gel Stain Sigma-Aldrich S5692
Alexa Fluor 647 NanoTemper Technologies NHS RED Kit
Kanamycin Sigma-Aldrich 60615
Gel and PCR Clean-up kit Macherey-Nagel 740609
Gibson assembly kit New England Biolabs E5510S
PierceTM BCA Protein Assay Thermo Fisher 23225
Nucleospin plasmid purification kit Macherey-Nagel 740588
HPLC column Agilent Hi-Plex H column for
carbohydrates
UPLC Column HSS T3 Waters Waters Acquity UPLC HSS T3
Verduyn minimal media (Verduyn et al, 1992) N/A
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Reagents and Tools table (continued)
Reagent/Resource Reference or source Identifier or catalog number
Software




gPROMS Model Builder v.4.0 gPROMS Model Builder v.4.0 N/A
Software for Accuri flow cytometer CFlow Plus Analysis N/A
Kaluza Analysis Software N/A
R version 3.4.0, RStudio version 1.0.143 https://www.R-project.org/,https://
rstudio.com/
N/A
Python version 3.6.2 https://www.python.org/ N/A
BudJ (Ferrezuelo et al, 2012) N/A
ImageJ (Abràmoff et al, 2004) N/A
General algebraic modeling system (GAMS) https://www.gams.com/
Thermodynamic constraint-based metabolic model (Niebel et al, 2019) N/A




SafeQuant R script (Ahrné et al, 2016) N/A
FoldX (Guerois et al, 2002) N/A
GraphPad Prism 8 https://www.graphpad.com N/A
SnapGene https://www.snapgene.com N/A




1290 LC HPLC system Agilent N/A
Dionex Ultimate 3000 RS UHPLC Dionex N/A
MDS Sciex API365 tandem mass spectrometer Ionics N/A
Turbo-Ion spray source MDS Sciex N/A
BD AccuriTM C6 flow cytometer BD Biosciences N/A
LTQ-Orbitrap Elite mass spectrometer Thermo Fisher N/A
CFX96 Real-Time System combined with C1000 Touch Thermal
Cycler
Bio-Rad N/A
Typhoon 9400 Amersham Biosciences N/A
Microfluidic chip (Lee et al, 2012; Huberts et al, 2013) N/A
Eclipse Ti-E inverted fluorescence microscope Nikon N/A
pE2 LED-based excitation system CoolLED N/A
Andor 897 Ultra EX2 EM-CCD camera Andor N/A
Methods and Protocols
Generation and cloning of the CggR cis-regulatory element and
reporter plasmid
The overall architecture of the four promoter elements is outlined in
the main text. The total DNA fragment size of all promoter element
was 562 bp. This DNA fragment included two ends complementary
to the reporter plasmid to allow for the Gibson assembly of the
reporter plasmid and the synthetic promoter. The complementary
flanking sites of the promoter element had a size of 100 bp at the 50
end and 145 bp at the 30 end.
The first promoter elements were composed of the wild-type
sequence of the CYC1 core promoter (core promoter of CYC1). In the
second promoter construct, the cggR-binding elements were intro-
duced by replacing the sequences of the CYC1 promoter at the inser-
tion positions (core-CYC1 with cggRO). In addition, two synthetic
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promoter sequences were generated using a computational method
to minimize nucleosome affinity (Curran et al, 2014). The initial
sequence of the CggR cis-regulatory element was generated with a
random sequence used as the starting point for further sequence
optimization (syn CggRO promoter V1). The functional elements of
this synthetic construct, i.e., the CggR operator site, the TATA boxes,
and the 50UTR, were excluded from the sampling procedure and thus
remained conserved. The algorithm was run for 75 rounds. The
version 38 (syn CggRO promoter V38) of the optimized CggR cis-
regulatory element was selected since it showed the lowest affinity
to nucleosomes and it was still feasible to be synthesized. DNA
synthesis was performed with a STRINGTM DNA fragment (GenArtTM,
Thermo Fisher Scientific, MA, USA) and directly used for the assem-
bly of the reporter plasmid. The functional DNA sequences of the
CggR cis-regulatory element and their distance from the 50 end of the
synthesized fragment are listed in Appendix Table S1, and the
synthesized sequences are given in Appendix Table S2.
To account for extrinsic cell-to-cell variation in the state of the
gene and protein expression machinery, a constitutively expressed
mCherry reporter was inserted into the low copy p416-loxP-KmR-
TEFmut6-yECitrine centromeric plasmid (Nevoigt et al, 2006). The
mCherry cassette included the mCherry ORF, the constitutive TEF1
promoter mutant 8 (PTEFmut8), and the ADH1 terminator, amplified
from the plasmids pBS35, p416-loxP-KmR-TEFmut8-yECitrine, and
pWHE601 (Appendix Table S5), respectively, with the primers listed
in Appendix Table S6. The three DNA fragments, i.e., PTEFmut8,
mCherry, and ADH1 terminator, were assembled by PCR using the
Phusion High-Fidelity DNA Polymerase (New England Biolabs,
MA, USA) and the mCherry_KpnI_fw and mCherry_KpnI_rv primers
(Appendix Table S6). The resulting 1.4-bp DNA fragment was puri-
fied, digested with KpnI, and purified again with PCR Clean-up kit
(Macherey-Nagel, Germany). The p416-loxP-KmR-TEFmut6-yECi-
trine plasmid was linearized with KpnI and dephosphorylated with
Antarctic Phosphatase (New England Biolabs, MA, USA), and
ligated with the mCherry expression cassette by T4 DNA ligase
(New England Biolabs, MA, USA). The ligation assay was trans-
formed into chemical competent E. coli DH5alpha cells. Clone
screening was performed by sequencing the extracted plasmids with
the primers listed in Appendix Table S6.
To construct a plasmid carrying the regulated CggR promoter, we
used the p416-loxP-KmR-TEFmut6-yECitrine with the inserted
mCherry cassette (pTEF6-7) (Appendix Table S5) and replaced the
PTEFmut6 promoter by the CggR cis-regulatory element using Gibson
assembly. The backbone of the pTEF6-7 plasmid was divided into
three fragments, which were amplified by PCR using the primers
listed in Appendix Table S6. The three backbone fragments were
combined together with the synthesized CggR cis-regulatory element
using the NEB Gibson assembly kit (New England Biolabs, MA, US)
according to the manufacturer instructions. 5 ll of reaction mix
was transformed into chemical competent E. coli cells. Clone
screening was performed to isolate the correct assembled pCggRO-
reporter plasmid. The plasmid sequence was verified by Sanger
sequencing of the extracted plasmids with the primers listed in
Appendix Table S6.
Cloning of the CggR regulator and its variants and promoters
The open reading frame of the transcription regulator CggR of
B. subtilis was codon-optimized for expression in S. cerevisiae. A
His6 and an Xpress epitope tag were added at the N-terminus of the
protein. The CggR sequence was assembled from synthetic oligonu-
cleotides (Thermo Fisher Scientific GeneArt AG, Germany), and the
ORF was subcloned in the pET100/D-TOPO express cloning vector.
Next, a Gibson assembly (New England Biolabs, MA, USA) was
carried out to generate an expression cassette of the cggR gene for
further integration in the HO locus of S. cerevisiae genome. To allow
for integration, the cggR gene was cloned into the integrative plas-
mid HO-poly-KanMX4-HO, where the KanMX4 resistance marker
was replaced by the ble resistance gene. To select for the transfor-
mants, we either used ura- auxotrophy or phleomycin, for WT or
TM6, respectively.
Promoter and terminator of the cmv gene were amplified from
the pCMV149 with a 50 and 30 overhang of a homologous sequence
to the codon-optimized cggR gene. The three DNA fragments, i.e.,
the cggR gene, the CMV promoter (PCMV), and terminator, were
combined together by PCR using the Phusion High-Fidelity DNA
Polymerase (New England Biolabs, MA, USA). The resulting frag-
ment was 2.2 kbp was gel-purified. A Gibson assembly was carried
out to link all DNA fragments and assemble the final integrative
pHO_pCMV_CggR_ble plasmid using the NEB Gibson assembly kit
(New England Biolabs, MA, US). 5 ll of reaction mix was trans-
formed into chemical competent E. coli DH5alpha cells. Clone
screening was performed by sequencing the extracted plasmids. All
the plasmids and primers used to generate the integrative plasmids
are listed in Appendix Tables S5 and S6, respectively. Additionally,
the constitutive promoters TEF mutant 2 (PTEFmut2) and mutant 7
(PTEFmut7) (Nevoigt et al, 2006) were also cloned for testing the
effect of different expression CggR levels on the biosensor output.
PTEFmut2 and PTEFmut7 were amplified from p416-loxP-KmR-
TEFmut2-yECitrine and p416-loxP-KmR-TEFmut7-yECitrine, respec-
tively, and used to replace the PCMV in the pHO_pCMV_CggR_ble
plasmid.
To address the effect of a lower KD toward FBP, the CggR mutant
variant R250A was inserted in the above generated plasmids (re-
placing the CggR wild type) using the NEB Gibson assembly kit
(New England Biolabs, MA, US). 5 ll of reaction mix was trans-
formed into chemical competent E. coli cells. Clone screening was
performed by sequencing the extracted plasmids. The set of primers
used for each integrative plasmid generation is listed in
Appendix Table S7. The strains generated and used throughout this
work are listed in Appendix Table S8.
Cultivation and experimental sampling
All strains were cultivated in 500-ml Erlenmeyer shake flask
containing 50 ml of minimal medium (Verduyn et al, 1992) inocu-
lated with exponentially growing yeast cells to an initial OD600 of
0.1–0.2 (ca. 1–2 × 107 cells). To adapt to the carbon source and to
ensure metabolic steady state, two pre-culturing steps were carried
out prior to the main culture. The inoculum was prepared in the
identical minimal medium. All cultivations were performed at 30°C,
and cultures were continuously shaken at 300 rpm. The medium
was buffered at pH 5 with 10 mM KH phthalate. Cells were cultured
in different carbon sources that would generate distinct glycolytic
fluxes and, as a consequence, FBP levels. Specifically, WT cells
were grown in minimal medium containing 10 g/l of glucose, galac-
tose, or pyruvate and TM6 cells were cultured in minimal medium
containing 10 g/l of maltose, glucose, or pyruvate.
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Cell counts were performed by flow cytometry (BD AccuriTM C6
Flow Cytometer, BD Biosciences, CA, USA) every hour for glucose,
galactose, and maltose. YFP and mCherry expression was assessed
by measuring the fluorescence along culture time using flow cytom-
etry through the FL1-A and FL3-A filters, respectively. Autofluores-
cence was assessed by measuring the fluorescence in cells
containing the centromeric yeast plasmid YCplac33 (Gietz & Akio,
1988) as a control using the FL1 and FL3 filters.
To determine the production and consumption rates of metabo-
lites during the cultivation, supernatant samples were taken every
hour from the cultivations. 0.3 ml of the broth sample was centri-
fuged at 13 rpm for 2 min to separate the cells from the super-
natant. The supernatant was transferred to filter columns (SpinX,
pore size: 0.22 lm), spun shortly, and stored at 20°C until HPLC
analyses were performed. At the end, the yeast dry mass was deter-
mined by filtering a certain volume of culture through pre-weighed
nitrocellulose filters with a pore size of 0.2 lm. Filters were washed
once with distilled water and kept at 80°C for 2 days. Afterward,
they were weighed again. The cell dry mass at every measurement
point was re-calculated from cell count and the dry mass cell count/
ratio using the dry mass cell count/ratio obtained at the end of the
fermentation.
Quantification of physiological parameters
Glucose, pyruvate, glycerol, acetate, and ethanol concentrations in
the cultivation supernatant were determined by HPLC (Agilent,
1290 LC HPLC system) using a Hi-Plex H column and 5 mM H2SO4
as eluent at a constant flow rate of 0.6 ml/min. The column temper-
ature was kept constant at 60°C. A volume of 10 ll of standards and
samples was injected for analysis. Substrate concentrations were
detected with refractive index and UV (constant wavelength of
210 nm) detection. The chromatogram integration was done with
Agilent Open Lab CDS software. Substrate and metabolite concen-
tration were calibrated prior to the analysis of the fermentation
samples using HPLC standards, which included all metabolites, rele-
vant for the various conditions. The external standards covered the
metabolites’ concentration range which was observed from the start
until the end of the fermentation.
Carbon uptake rate calculations were performed using the time-
course data of the exponentially growing cultures of the different
strains and carbon sources. From at least three independent biological
replicates, the extracellular rates were estimated from measured
concentration–time courses, e.g., glucose, ethanol, acetate, glycerol,
pyruvate, and biomass, of the batch cultivation. Extracellular rates
were estimated by fitting the concentration–time courses to a mathe-
matical model assuming exponential growth and constant yields in the
culture. The regression and parameter estimation were implemented in
gPROMS Model Builder v.4.0 (Process Systems Enterprise Ltd.).
Quantification of intracellular metabolite levels
A sample of 3 × 107 cells was taken and immediately quenched in
10 ml methanol, which was beforehand cooled down to 40°C. The
cells were separated from the organic solvent by centrifugation
(5 min, 21,000 g, 4°C), washed with 2 ml methanol, separated again
by centrifugation, and stored at 80°C. For the following analysis,
the cell pellet was resuspended in extraction buffer (methanol,
acetonitrile, and water, 4:4:2 v/v/v supplemented with 0.1 M formic
acid) and an internal standard of 13C-labeled metabolites was added
to the extraction. This standard was obtained and quantified from
exponentially grown cell cultures prior to the experiment. The
extraction was agitated for 10 min at room temperature and there-
after centrifuged at maximum speed. The supernatant was trans-
ferred to a new vial and the cell pellet resuspended in extraction
buffer and the extraction procedure was repeated a second time. The
supernatants from both steps were combined and centrifuged for
45 min at 4°C and 21,000 g to remove any remaining non-soluble
parts. Thereafter, the supernatant was vacuum-dried at 45°C for
approximately 1.5 h and subsequently re-dissolved in 200 ll water.
The extracted intracellular metabolites were identified and quanti-
fied using a UHPLC-MS/MS system as done previously (Radzikowski
et al, 2016). Specifically, the chromatographic separation was
performed on a Dionex Ultimate 3000 RS UHPLC (Dionex, Germering,
Germany) equipped with a Waters Acquity UPLC HSS T3 ion pair
column with pre-column (dimensions: 150 × 2.1 mm, particle size:
3 lm; Waters, Milford, MA, USA). The injection volume was 10 ll,
and the samples were permanently cooled at 4°C. A binary solvent
gradient was employed (0 min: 100% A; 5 min: 100% A; 10 min:
98% A; 11 min: 91% A; 16 min: 91% A; 18 min: 75% A; 22 min:
75% A; 22 min: 0% A; 26 min: 0% A; 26 min: 100% A; 30 min:
100% A) at a flow rate of 0.35 ml/min, where solvent A was
composed of 5% (v/v) methanol in water supplemented with 10 mM
tributylamine, 15 mM acetic acid, and 1 mM 3,5-heptanedione and
isopropanol as solvent B. The detection was done using multiple reac-
tion monitoring (MRM) on a MDS Sciex API365 tandem mass spec-
trometer upgraded to EP10 + (Ionics, Bolton, Ontario, Canada) and
equipped with a Turbo-Ion spray source (MDS Sciex, Nieuwerkerk aan
den Ijssel, Netherlands) with the following source parameter: NEB
(nebulizing gas, N2): 12 a.u., CUR (curtain gas, N2): 12 a.u., CAD (col-
lision activated dissociation gas): 4 a.u., IS (ion spray voltage):
4,500 V, and TEM (temperature): 500°C.
The amounts of metabolites determined in each sample were
converted into intracellular concentrations, using the determined
number of cells in the sample and the respective cell volume. The
cell volume was determined by taking an image of mid-exponential
cells of wild type (WT) and TM6 in various conditions. The cells
were placed on a microscopic slide. Approximately 200 cells per
condition and replicate were evaluated on several positions/images
of the microscopic slide. The cell volume was estimated using BudJ
plugin of ImageJ (Ferrezuelo et al, 2012).
Determination of intracellular fluxes
To estimate the glycolytic flux for the two strains and the different
substrate conditions, we used a thermodynamic constraint-based
metabolic model, and a new approach for metabolic flux analysis
(Niebel et al, 2019). The model and constraints were based on
what we previously used, but the network was extended by reac-
tions describing the uptake and metabolization of galactose and
maltose (Appendix Tables S10 and S11). The model was fitted to
experimental data, which here comprised of intracellular metabo-
lite concentrations, extracellular fluxes (as measured for the dif-
ferent conditions and strain), and standard Gibbs free energies of
reaction (DrG°), determined from the component contribution
method (Noor et al, 2013). The experimental data of all six condi-
tions are given in Appendix Tables S12 and S13. The fitting was
done as previously, i.e., jointly for all conditions to identify one
condition-dependent set of DrG⁰, but without regularization. The
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result of the regression analysis and the goodness of fit are
presented in Appendix Fig S9. Next, we performed a flux variabil-
ity analysis to determine the limits of the solution space of each
flux for all growth conditions and the two strains, for which the
fitted values of the measured extracellular fluxes were allowed to
vary  2.95 standard deviations. Within those limits, 1000 flux
distributions were sampled for each condition with optGpSampler
(Megchelenbrink et al, 2014) using linear approximations for the
non-linear thermodynamic constraints, as we did previously
(Niebel et al, 2019). The mean and standard error of each meta-
bolic flux at each condition were determined from this sample
population.
Quantification of CggR and mCherry levels
Intracellular CggR and mCherry levels were quantified in CMV,
PTEFmut2, and PTEFmut7_CggR yeast strains. WT and TM6 cells were
grown using the same scheme as described above. Cell counts were
monitored by flow cytometry (BD AccuriTM C6 flow cytometer (BD
Biosciences, CA, USA), and cells were harvested once they reached
a concentration of 107 cells/ml. To do so, 10 ml of cells was pelleted
(ca. 108 cells per sample), washed twice with ice-cold PBS (0.1 mM
Na2HPO4, 0.018 mM KH2PO4, 1.37 mM NaCl, 0.027 mM KCl), and
centrifuged at 10,000× g, at 4°C for 10 min. The cell pellet was
frozen in liquid nitrogen and stored at 80°C until further analysis.
For each strain, three biological replicates and three technical repli-
cates were taken.
The cell pellet was reconstituted in 40 ll 2% sodium deoxy-
cholate (SDC); 10 mM TCEP; and 100 mM ammonium bicarbonate
and sonicated two times for 10 s using a UP200St with VialTweeter
(Hielscher Ultrasonics GmbH, Germany). Heat treatment was
performed for 10 min at 95°C. After cooling, the protein concentra-
tion was determined by BCA assay for each sample (Thermo Fisher
Scientific, MA, USA). Sample aliquots containing 100 lg protein
were used for the following steps. Alkylation was performed by
adding iodoacetamide to a final concentration of 15 mM and incuba-
tion for 45 min at RT, in the dark. The samples were diluted to 1%
SDC using 100 mM ammonium bicarbonate and mass spectrometry
grade trypsin (Promega, WI, USA) was added at a ratio of 1:50 (lg
trypsin:lg protein) and samples were incubated overnight at 37°C,
400 rpm. The reaction was stopped by adding trifluoroacetic acid to
a final concentration of 1%. Sample clean-up by solid-phase extrac-
tion was performed with Pierce C18 tips (Thermo Fisher Scientific,
MA, USA) according to the manufacturer instructions. The eluate
fraction was dried under vacuum and reconstituted with 20 ll of a
mixture of 2% acetonitrile and 0.1% formic acid.
1 lg of peptides of each sample was subjected to LC-MS analysis
using a dual pressure LTQ-Orbitrap Elite mass spectrometer
connected to an electrospray ion source (Thermo Fisher Scientific,
MA, USA) as described recently (Ahrne´ et al, 2016) with a few
modifications. In brief, peptide separation was carried out using an
EASY nLC-1000 system (Thermo Fisher Scientific, MA, USA)
equipped with a RP-HPLC column (75 lm × 30 cm) packed in-
house with C18 resin (ReproSil-Pur C18–AQ, 1.9 lm resin; Dr.
Maisch GmbH, Ammerbuch-Entringen, Germany) using a linear
gradient from 95% solvent A (0.15% formic acid, 2% acetonitrile)
and 5% solvent B (98% acetonitrile, 0.15% formic acid) to 28%
solvent B over 100 min and to 45% B over 20 min at a flow rate of
0.2 ll/min. The data acquisition mode was set to obtain one
high-resolution MS scan in the FT part of the mass spectrometer at a
resolution of 120,000 full width at half-maximum (at m/z 400)
followed by MS/MS scans in the linear ion trap of the 20 most
intense ions using rapid scan speed. The charged state screening
modus was enabled to exclude unassigned and singly charged ions,
and the dynamic exclusion duration was set to 60 s. The ion accu-
mulation time was set to 300 ms (MS) and 25 ms (MS/MS).
For label-free quantification, the generated raw files were
imported into the Progenesis QI software (Nonlinear Dynamics
(Waters), Version 2.0) and analyzed using the default parameter
settings. MS/MS data were exported directly from Progenesis QI in
mgf format and searched against a decoy database the forward and
reverse sequences of the predicted proteome from Saccharomyces
cerevisiae (strain ATCC 204508/S288c, UniProt, download date: 15/
12/2016) including common contaminants, such as keratins and
CggR from Bacillus subtilis (strain 168, total of 14,248 entries)
using MASCOT (version 2.4.1). The search criteria were set as
follows: Full tryptic specificity was required (cleavage after lysine or
arginine residues); three missed cleavages were allowed; and
carbamidomethylation (C) was set as fixed modification and oxida-
tion (M) as variable modification. The mass tolerance was set to
10 ppm for precursor ions and 0.6 Da for fragment ions. Results
from the database search were imported into Progenesis QI, and the
final peptide measurement list containing the peak areas of all iden-
tified peptides, respectively, was exported. This list was further
processed and statically analyzed using our in-house developed
SafeQuant R script (Ahrne´ et al, 2016). The peptide and protein
false discovery rate (FDR) were set to 1% using the number of
reverse hits in the dataset.
The CggR intracellular abundance is the cell protein content of
CggR calculated using the iBAQ approach (Ahrne´ et al, 2013). The
relative abundance of CggR was calculated by normalizing the cell
protein content of CggR to the cell protein content of the CggR
measured on glucose and using same promoter.
In silico design of a CggR mutant library with altered affinity
for FBP
FoldX was used to predict the stability and structure of CggR
mutants (Guerois et al, 2002). FoldX evaluates the change in fold-
ing energy (ΔΔGfold) due to a point mutation. This ΔΔGfold equals
the Gibbs folding energy (ΔGfold) of the mutant minus the Gibbs
folding energy of the wild-type protein. The FoldX settings were as
default for the calculation of the stability effects of point mutations,
with averaging of five independent predictions per variant (Wijma
et al, 2018). In the dimeric CggR structure (PDB id: 3BXF), two
conformations occur because the binding of FBP to only one of the
subunits causes a local conformational change (Reza´cova´ et al,
2008). To model the effect of mutations on the equilibrium
between those two conformations, two dimer structures were
generated, in which the same conformation occurs in both subu-
nits. This was done by duplicating one subunit, superimposing the
resulting copy on the coordinates of the other subunit by a least-
squares fit, and then eliminating the original subunit at that posi-
tion. Suitable residues to mutate in the FBP-binding site were iden-
tified by visual inspection using Yasara (Krieger & Vriend, 2014).
From a total of 18 mutations predicted, 6 were selected to be tested
in vitro (Table 1) based on the desired mild impact on the dissocia-
tion constant (Kd) of CggR.
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Site-directed mutagenesis of CggR
For the generation of the CggR mutants with decreased FBP-binding
affinity, a site-directed mutagenesis approach based on PCR was
performed. The set of primers containing the mutation of interest
are listed in Appendix Table S9. All the PCRs were performed
according to the Phusion High-Fidelity DNA Polymerase (New
England Biolabs, MA, USA) protocol using 0.05 Units of Phusion
and 100 lM dNTPs in a total volume of 25 ll.
To eliminate contamination of the original template DNA, a DpnI
digestion was performed by adding 1 ll of DpnI to the PCR mix,
followed by an overnight incubation at 37°C. 9 ll of the DpnI diges-
tion product was then transformed into chemical competent E. coli
DH5alpha cells. Plasmid DNA extraction was done with the nucle-
ospin plasmid purification kit (Macherey-Nagel, Germany). The
confirmation of the mutated CggR variants was performed by
sequencing of the extracted plasmids.
CggR protein expression and purification
CggR wild type and the generated mutants were cloned in pET100/
D-TOPO (Thermo Fisher Scientific; Waltham, MA), with an N-term-
inal His6 tag and expressed in E. coli. All constructs were verified by
sequencing. For protein production, a single colony was used to
inoculate 50 ml LB containing 100 lg/ml ampicillin, and the culture
was grown at 37°C overnight. This culture was diluted to an optical
density (OD600) of 0.05 in a final volume of 2 l. Protein expression
was induced at OD600 0.5 by addition of 10 lM IPTG, and cells were
kept at 30°C and 180 rpm for four more hours. Cells were harvested
by centrifugation at 6,675× g at 4°C for 20 min and washed once
with 30 ml of 50 mM Tris–HCL buffer (pH 7.2). Cells were pelleted
at 3,000× g at 4°C for 40 min, frozen in liquid nitrogen, and stored
at 80°C until further use.
For protein purification, cell pellets were thawed on ice and
resuspended with 10 ml of icecold lysis buffer (50 mM KH2PO4,
300 mM NaCl, 1 mM EDTA, pH 7.5) per gram of cell pellet, and
lysed by high-pressure disruption (Constant Cell Disruption System,
Ltd, UK) in one passage at 25 Kpsi at 4°C. Prior to lysate centrifuga-
tion, 1 mM of PMSF, 20 mM MgCl2, and 10 lg/ml of DNase (Sigma-
Aldrich, MO, USA) were added. Cell debris was removed by
centrifugation at 35,200× g at 4°C for 20 min. The cleared lysate
was incubated with 0.5 ml of a nickel sepharose resin (GE Health-
care, Little Chalfont, UK), pre-equilibrated with 50 mM of KH2PO4
buffer (pH 7.5), and incubated at 4°C in batch mode overnight. The
nickel sepharose-lysate suspension was poured onto a 10-ml dispos-
able column (Bio-Rad), and the settled resin washed with 20 column
volumes of a first wash solution (50 mM KH2PO4, 300 mM NaCl,
60 mM imidazole, pH 7.5), followed by 20 column volumes of a
second wash solution (50 mM KH2PO4, 300 mM NaCl, 50 mM L-
histidine, pH 7.5). Protein elution was performed with 9 ml of
elution buffer (50 mM KH2PO4, 300 mM NaCl, 235 mM L-histidine,
pH 7.5).
Protein concentration was measured by absorbance at 280 nm
and extinction coefficient of 4.2. Protein purity and integrity
were evaluated by running the samples in a 10% SDS–PAGE gel
using protein concentrations of 0.1 mg/ml. A buffer exchange
(50 mM KH2PO4, 300 mM NaCl, pH 7.5) was performed on the
fractions with concentrations above 1 mg/ml and purity above
95%. The protein purified stocks were stored at 4°C until
needed.
Thermal shift assays
A sample mixture of 25 ll final volume containing 5 ll of 5×
SYPRO Orange (Molecular Probes; Eugene, OR), 0.2 mg of the
purified CggR, and different concentrations of the FBP metabolite
(0; 0.01; 0.1; 0.5; 0.75; 1; 2.5; 10; 20; and 36 mM) was prepared
on ice. Control experiments were performed to test the effect of
the counter ion NaCl present in FBP salt solutions. Here, the
NaCl was added instead of FBP to a final concentration threefold
higher than the FBP itself (0; 0.03; 0.3; 1.5; 2.25; 3; 7.5; 30; 60;
and 108 mM).
Sample mixtures were transferred into 96-well PCR plates (Bio-
Rad, CA, USA), sealed with Optical-Quality Sealing Tape (Bio-Rad,
CA, USA), and analyzed in a CFX96 Real-Time System combined
with C1000 Touch Thermal Cycler (Bio-Rad, CA, USA). Analysis
consisted of a single heating cycle from 20 to 99°C with increments
of 0.5°C steps, followed by fluorescence intensity monitoring with a
charge-coupled device camera. The wavelengths for excitation and
emission were 490 and 575 nm, respectively. The melting tempera-
ture (Tm) was automatically calculated by the control software and
corresponded to the local maximum of the first derivative of
measured fluorescence versus temperature.
The KD of the wild type and mutant CggR variants was calculated
by fitting the Tm data into a simple cooperative model using the
GraphPad software.
Electrophoresis mobility shift assay
Fluorescently labeled DNA fragments were generated by hybridiza-
tion of single-stranded forward (labeled with Alexa Fluor 647 at the
50 end) and reverse (unlabeled) oligonucleotides containing the
CggR operator sites. The hybridization protocol and respective
hybridization efficiency control were performed as described else-
where (Bley Folly et al, 2018).
Hybridized labeled DNA fragments (final concentration 35 nM)
were incubated 20 min at room temperature with 2 or 4 lM of the
purified wild type or mutant CggR variants, in the presence of dif-
ferent concentrations of FBP (0; 0.5; 1; 2.5; 5; 10; and 20 mM) in a
final volume of 25 ll in binding buffer (10 mM Na3PO4 pH 7.8,
100 mM NaCl, 1 mM EDTA, 1 mM DTT, 5% glycerol) including
1 lg of salmon sperm DNA. The sample mixtures were loaded in a
5% native polyacrylamide gel and run in native conditions in the
dark with constant voltage (200V) at 4°C for 2 h.
Fluorescence was imaged using the Typhoon 9400 (Amersham
Biosciences, UK) with the excitation set to 650 nm and the emission
set to 655 nm. The background-subtracted total intensities of the
protein–DNA complex and the free-DNA bands were assessed using
ImageJ (Abra`moff et al, 2004), and bound DNA/total DNA was
calculated by dividing the intensity of the protein–DNA complex
band by the total DNA (i.e., the sum of the signal from the protein–
DNA complex band plus the one from free DNA).
Time-lapse microscopic analyses
For testing the glycolytic flux-sensor output with microscopy, a
microfluidic device (Lee et al, 2012; Huberts et al, 2013) was used,
which was loaded with cells at log phase growing in glucose,
maltose, or galactose. Monitoring of cells took place using an
inverted fluorescence microscope (Eclipse Ti-E; Nikon). During the
experiment, a custom-made microscope incubator (Life Imaging
Services GmbH) retained the temperature constant at 30°C, and cells
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were continuously supplied with fresh medium. For illumination, an
LED-based excitation system (pE2; CoolLED) was used, and images
were recorded with an Andor 897 Ultra EX2 EM-CCD camera using
a CFI Plan Apo VC 60× Oil (NA = 1.4; Nikon) objective or a CFI
Super Fluor 100XS Oil (NA = 0.50–1.30; Nikon) objective (in the
experiments applying the sensor and unregulated control to the cell-
cycle context). 300-ms exposure time and 50% light intensity were
used for YFP (500-nm excitation using a 520/20-nm excitation filter
and a 515-nm beam splitter, 535/30-nm emission filter, EM gain
25), and 200-ms exposure time and 25% light intensity were used
for mCherry measurements (565-nm excitation using a 562/40-nm
excitation filter and a 593-nm beam splitter, 624/40-nm emission fil-
ter, EM gain 25). Brightfield images were recorded for cell segmen-
tation.
For comparing the flux-sensor output between co-existing high
flux (dividing) and low-flux (non-dividing) cells, TM6 cells from
log-phase (10 g/l glucose) cultures were loaded in the microfluidic
device, and after one initial round of fluorescence imaging, cells
were followed only with the brightfield channel for 20 h to deter-
mine budding activity. Cell segmentation to determine mean cell
YFP and mCherry fluorescence intensities was performed with the
ImageJ plugin BudJ (Ferrezuelo et al, 2012) using the brightfield
images. Before computing the YFP to mCherry ratio for each cell,
fluorescent intensity measurements were corrected for background
fluorescence by subtracting the modal gray value of the whole
image area in each fluorescent channel. Statistical analyses and plot-
ting were performed in GraphPad.
In the experiments applying the sensor and unregulated control
to the cell-cycle context, TM6 cells from log-phase cultures (20 g/l
glucose) were loaded in the microfluidic device, where fresh 20 g/l
glucose medium was provided at the flow rate of 4 ll/min with the
help of a syringe pump. Microscopic imaging was performed in the
YFP, mCherry, and brightfield channels every 6 min. Images in the
fluorescent channels were background-corrected via rolling ball
background subtraction plugin of ImageJ, and images in the bright-
field channel were sharpened and contrast-enhanced in ImageJ.
Cells were tracked throughout a microscopy movie and segmented
by fitting an ellipse in the brightfield image at each time point via
the semi-automated plugin BudJ (Ferrezuelo et al, 2012) used with
ImageJ. In parallel, by visual inspection and with the help of a
custom macro, we recorded for each segmented cell the time points
of budding events (appearance of a dark-pixel cluster from which a
daughter cell would later grow) and of cytokinesis events (one time
point before the daughter cell would rapidly detach from the mother
cell, sometimes accompanied by the appearance of a dark-pixel line
between the mother and daughter cells). To analyze cellular fluores-
cence data, we uploaded the background-corrected microscopy
movie into a NumPy multidimensional array via Python’s module
scikit-image and extracted the pixels corresponding to a cell of inter-
est by overlapping the array with the segmentation ellipses provided
by BudJ. To work with a continuous cell volume trajectory V(t){fl}
without abrupt drops corresponding to cytokineses, we considered a
cell cycle to be confined between two cytokineses (cyt), excluding
the first but including the last one: t 2 ðcyti; cytiþ1Þmin. We calcu-
lated the volumes of the mother and daughter cells Vm and Vd sepa-
rately, using the radii of the ellipse that ImageJ’s plugin BudJ fitted
to the mother and daughter cells in the brightfield image. We
assumed that the mother and daughter cells are prolate spheroids;
therefore, Vm and Vd were calculated via 43 pRr
2, where R and r are
the major and minor radii, respectively. Given the microscope’s
resolution, it was infeasible to accurately segment daughter cells
with BudJ for several time points after budding. In these time
points, the daughter cell volume was reconstructed using linear
interpolation between the zero volume at budding and the first
volume calculation on the basis of BudJ-derived radii. Eventually, a
cell-cycle trajectory of the cell volume was assembled as follows:
VðtÞ ¼ VmðtÞ þ VdðtÞ, t 2 ðcyti, cytiþ1Þ, with Vd(t) equal to zero until
budding. We visually inspected the cell-cycle trajectories of cell
volume as well as YFP and mCherry fluorescence averaged across
the mother-cell pixels, and removed those cell cycles from the analy-
sis that suffered from bad cell segmentation and noisy signals. In
some cell cycles, we also removed single data points corresponding
to abnormally high or low cell volume explained by bad cell
segmentation. We smoothed the cell volume, YFP, and mCherry
trajectories to filter out local fluctuations caused by imperfect
segmentation and to capture visible global behavior. To support
smoothing at the beginning and end of a cell-cycle trace, we used
the data in the adjacent 50 min of the preceding and following cell
cycles. The smoothing was performed via the Gaussian process
regression (Python’s sklearn.gaussian_process) using as a prior the
radial basis function kernel with the length-scale range [30,48]
{min} and the white kernel with the free noise level, and
maximizing the log-marginal likelihood. The smoothed trajectories
of cell volume, mother-cell YFP, and mCherry fluorescence,
Vsmooth(t), FsmoothYFP ðtÞ, and FsmoothmCherryðtÞ, t 2 ðcyti  50, cytiþ1 þ 50Þ, were
used to calculate the YFP and mCherry abundances
AXðtÞ ¼ VsmoothðtÞFsmoothX ðtÞ, X 2 fYFP,mCherryg. In turn, these
abundances were employed to calculate the production rates in the
first-order maturation kinetics model: rXðtÞ ¼ t1=2ðXÞln2  d
2AX ðtÞ
dt2 þ dAX ðtÞdt ,
t 2 ½cyti, cytiþ1, where t1/2(X) is the maturation half-time assumed
to be 20 min for YFP and 50 min for mCherry (varying these param-
eters around these values did not markedly influence the results of
the Fig 7F and G). Next, we detrended rXðtÞ ! rXðtÞ by subtracting
the line connecting rX(cyti) and rX(cyti+1), and normalized this
trajectory so that its minimum becomes 0 and maximum 1:
~rX ¼ rXðtÞminðrX ðtÞÞmaxðrX ðtÞÞminðrX ðtÞÞ. To determine the uncoupling between the
YFP and mCherry production rates during the cell cycle, we calcu-
lated the following difference: ~rYFPðtÞ  ~rmCherryðtÞ. This analysis was
implemented in Python with the help of the modules pandas,
numpy, scipy, sklearn, matplotlib, seaborn, and skimage in the
Jupyter notebook environment.
Data availability
The datasets produced in this study are available in the following
databases:
• Mass spectrometry raw data: ProteomeXchange Consortium
PXD012964, http://proteomecentral.proteomexchange.org (via
the PRIDE partner repository (Vizcaı´no et al, 2013).
• Plasmids have been deposited at Addgene (plasmids #124582,
#124583, #124584, and #124585).
Expanded View for this article is available online.
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